Clinical Trials Listing Service

Sickle Cell Single/Multiple Dose Study

Last updated: N/A
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

N/A

Condition

Sickle Cell Disease

Treatment

N/A

Clinical Study ID

TX238102
  • Ages 18-60
  • All Genders

Study Summary

A randomized, placebo-controlled, double blind, single ascending and multiple ascending dose study to assess the safety in healthy volunteers and sickle cell disease. Facility is in Miami, Florida.

Eligibility Criteria

Inclusion

  • Ages 18 to 60
  • Subjects must be in general good health
  • Subjects must have a negative urine test for drugs and alcohol abuse

Study Design

Study Start date:
Estimated Completion Date:

Study Description

Connect with a study center

  • Advanced Pharma - Miami

    Miami, Florida 33147
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.